COMPARISON OF RENIN AND CONVERTING ENZYME-INHIBITION IN SODIUM-DEFICIENT DOGS

被引:28
作者
BLAINE, EH [1 ]
NELSON, BJ [1 ]
SEYMOUR, AA [1 ]
SCHORN, TW [1 ]
SWEET, CS [1 ]
SLATER, EE [1 ]
NUSSBERGER, J [1 ]
BOGER, J [1 ]
机构
[1] MERCK INST THERAPEUT RES, MERCK SHARP & DOHME RES LABS, RAHWAY, NJ 07065 USA
关键词
D O I
10.1161/01.HYP.7.3_Pt_2.I66
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:I66 / I71
页数:6
相关论文
共 35 条
[1]   PRESSOR-RESPONSE TO 1-SAR-8-ALA-ANGIOTENSINII (SARALASIN) IN HYPERTENSIVE SUBJECTS [J].
ANDERSON, GH ;
STREETEN, DHP ;
DALAKOS, TG .
CIRCULATION RESEARCH, 1977, 40 (03) :243-250
[2]   VASCULAR WALL RENIN IN SPONTANEOUSLY HYPERTENSIVE RATS - POTENTIAL RELEVANCE TO HYPERTENSION MAINTENANCE AND ANTIHYPERTENSIVE EFFECT OF CAPTOPRIL [J].
ASAAD, MM ;
ANTONACCIO, MJ .
HYPERTENSION, 1982, 4 (04) :487-493
[3]   STATINE-CONTAINING RENIN INHIBITOR - DISSOCIATION OF BLOOD-PRESSURE LOWERING AND RENIN INHIBITION IN SODIUM-DEFICIENT DOGS [J].
BLAINE, EH ;
SCHORN, TW ;
BOGER, J .
HYPERTENSION, 1984, 6 (02) :I111-I118
[4]  
BLAIRWEST JR, 1971, AM J PHYSIOL, V220, P1309
[5]   NOVEL RENIN INHIBITORS CONTAINING THE AMINO-ACID STATINE [J].
BOGER, J ;
LOHR, NS ;
ULM, EH ;
POE, M ;
BLAINE, EH ;
FANELLI, GM ;
LIN, TY ;
PAYNE, LS ;
SCHORN, TW ;
LAMONT, BI ;
VASSIL, TC ;
STABILITO, II ;
VEBER, DF ;
RICH, DH ;
BOPARI, AS .
NATURE, 1983, 303 (5912) :81-84
[6]   ROLE OF KININS IN THE ACUTE ANTIHYPERTENSIVE EFFECT OF THE CONVERTING ENZYME-INHIBITOR, CAPTOPRIL [J].
CARRETERO, OA ;
MIYAZAKI, S ;
SCICLI, AG .
HYPERTENSION, 1981, 3 (01) :18-22
[7]   ROLE OF ANGIOTENSIN IN THE CONTROL OF BLOOD-PRESSURE DURING SODIUM DEPLETION [J].
CONWAY, J ;
HATTON, R ;
KEDDIE, J ;
DAWES, P .
HYPERTENSION, 1979, 1 (04) :402-409
[8]   ANGIOTENSIN-I CONVERTING ENZYME [J].
ERDOS, EG .
CIRCULATION RESEARCH, 1975, 36 (02) :247-255
[9]   COMPARATIVE-STUDY OF AN ANGIOTENSIN-II ANALOG AND A CONVERTING ENZYME-INHIBITOR [J].
FAGARD, RH ;
AMERY, AK ;
LIJNEN, PJ ;
REYBROUCK, TM .
KIDNEY INTERNATIONAL, 1980, 17 (05) :647-653
[10]   HEMODYNAMIC AND ANTIHYPERTENSIVE EFFECTS OF THE NEW ORAL ANGIOTENSIN-CONVERTING-ENZYME INHIBITOR MK-421 (ENALAPRIL) [J].
FOUAD, FM ;
TARAZI, RC ;
BRAVO, EL ;
TEXTOR, SC .
HYPERTENSION, 1984, 6 (02) :167-174